Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.
Yanagisawa T, Rajwa P, Thibault C, Gandaglia G, Mori K, Kawada T, Fukuokaya W, Shim SR, Mostafaei H, Motlagh RS, Quhal F, Laukhtina E, Pallauf M, Pradere B, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. Among authors: pallauf m. Eur Urol. 2022 Dec;82(6):584-598. doi: 10.1016/j.eururo.2022.08.002. Epub 2022 Aug 19. Eur Urol. 2022. PMID: 35995644 Free article. Review.
En Bloc Resection for Bladder Tumors: An Updated Systematic Review and Meta-Analysis of Its Differential Effect on Safety, Recurrence and Histopathology.
Yanagisawa T, Mori K, Motlagh RS, Kawada T, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Aydh A, König F, Pallauf M, Pradere B, D'Andrea D, Compérat E, Miki J, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. Among authors: pallauf m. J Urol. 2022 Apr;207(4):754-768. doi: 10.1097/JU.0000000000002444. Epub 2022 Jan 21. J Urol. 2022. PMID: 35060770
Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics.
König F, Grossmann NC, Soria F, D'Andrea D, Juvet T, Potretzke A, Djaladat H, Ghoreifi A, Kikuchi E, Hayakawa N, Mari A, Khene ZE, Fujita K, Raman JD, Breda A, Fontana M, Sfakianos JP, Pfail JL, Laukhtina E, Rajwa P, Pallauf M, Cacciamani GE, van Doeveren T, Boormans JL, Antonelli A, Jamil M, Abdollah F, Budzyn J, Ploussard G, Heidenreich A, Daneshmand S, Boorjian SA, Rouprêt M, Rink M, Shariat SF, Pradere B. König F, et al. Among authors: pallauf m. Cancers (Basel). 2022 Mar 31;14(7):1781. doi: 10.3390/cancers14071781. Cancers (Basel). 2022. PMID: 35406553 Free PMC article.
Circulating Tumour DNA Is a Strong Predictor of Outcomes in Patients Treated with Systemic Therapy for Urothelial Carcinoma.
Laukhtina E, Hassler MR, Pradere B, Yanagisawa T, Quhal F, Rajwa P, Sari Motlagh R, König F, Pallauf M, Kawada T, Mostafaei H, D'Andrea D, Enikeev D, Shariat SF. Laukhtina E, et al. Among authors: pallauf m. Eur Urol Focus. 2022 Nov;8(6):1683-1686. doi: 10.1016/j.euf.2022.04.017. Epub 2022 May 11. Eur Urol Focus. 2022. PMID: 35562252 Free article. Review.
Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis.
Yanagisawa T, Mori K, Kawada T, Motlagh RS, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Aydh A, König F, Pallauf M, Pradere B, Miki J, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. Among authors: pallauf m. Urol Oncol. 2022 Jul;40(7):315-330. doi: 10.1016/j.urolonc.2022.04.002. Epub 2022 May 11. Urol Oncol. 2022. PMID: 35562311 Free article. Review.
Diagnostic Performance of Prostate-specific Membrane Antigen Positron Emission Tomography-targeted biopsy for Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis.
Kawada T, Yanagisawa T, Rajwa P, Sari Motlagh R, Mostafaei H, Quhal F, Laukhtina E, Aydh A, König F, Pallauf M, Pradere B, Ceci F, Baltzer PAT, Hacker M, Rasul S, Karakiewicz PI, Araki M, Nasu Y, Shariat SF. Kawada T, et al. Among authors: pallauf m. Eur Urol Oncol. 2022 Aug;5(4):390-400. doi: 10.1016/j.euo.2022.04.006. Epub 2022 Jun 15. Eur Urol Oncol. 2022. PMID: 35715320 Free article. Review.
A Systematic Review and Meta-Analysis of Prognostic Nomograms After UTUC Surgery.
Pallauf M, König F, D'Andrea D, Laukhtina E, Mostafaei H, Motlagh RS, Quhal F, Aydh A, Yanagisawa T, Kawada T, Rajwa P, Lusuardi L, Soria F, Karakiewicz PI, Rouprêt M, Rink M, Lotan Y, Margulis V, Singla N, Xylinas E, Shariat SF, Pradere B. Pallauf M, et al. Front Oncol. 2022 Jul 1;12:907975. doi: 10.3389/fonc.2022.907975. eCollection 2022. Front Oncol. 2022. PMID: 35847838 Free PMC article.
Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis.
Yanagisawa T, Kawada T, Rajwa P, Mostafaei H, Motlagh RS, Quhal F, Laukhtina E, König F, Pallauf M, Pradere B, Karakiewicz PI, Nyirady P, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. Among authors: pallauf m. Urol Oncol. 2023 Apr;41(4):177-191. doi: 10.1016/j.urolonc.2022.06.018. Epub 2022 Aug 13. Urol Oncol. 2023. PMID: 35970698 Free article. Review.
66 results